[1]
Rani, B.R., Kumar, M.A., Babu, K.S. and Rao, T.N. 2022. An open label randomized placebo-controlled study of apremilast in common immune mediated papulosquamous hair and pigmentary dermatoses. International Journal of Research in Dermatology. 8, 2 (Feb. 2022), 254–259. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20220495.